Concert Pharmaceuticals, Inc. Increase (Decrease) in Restricted Cash
Concert Pharmaceuticals, Inc. reported Increase (Decrease) in Restricted Cash of $1.16 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-01
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $0.00.
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2017 was $1.16M.
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2016 was $0.00.
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2015 was $0.00.
- Concert Pharmaceuticals, Inc. increase (decrease) in restricted cash for fiscal 2014 was -$306.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|
| 2017-12-31 | $1.16M 10-K · filed 2018-03-01 | ||
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$306.00K 10-K · filed 2017-03-06 | |
| 2014-09-30 | -$306.00K 10-Q · filed 2015-11-05 | ||
| 2013-12-31 | $0.00 10-K · filed 2016-03-01 |